(7alpha,9xi)-6-(acetyloxy)-3,5,7,10,16-pentahydroxygrayanotoxan-14-yl propanoate (56662-60-3)

Identification
Name:	(7alpha,9xi)-6-(acetyloxy)-3,5,7,10,16-pentahydroxygrayanotoxan-14-yl propanoate
Synonyms:	Pieristoxin F;AC1MJ3VZ;56662-60-3;Grayanotoxane-3,5,6,7,10,14,16-heptol, 6-acetate 14-propanoate, (3beta,6beta,7alpha,14R)-
CAS:	56662-60-3
Molecular Formula:	C₂₅H₄₀O₉
Molecular Weight:	484.5797
InChI:	InChI=1/C25H40O9/c1-7-17(28)34-19-13-8-9-14-23(6,31)15-10-16(27)21(3,4)25(15,32)20(33-12(2)26)18(29)24(14,19)11-22(13,5)30/h13-16,18-20,27,29-32H,7-11H2,1-6H3/t13?,14?,15-,16?,18+,19?,20?,22+,23+,24?,25-/m0/s1
Molecular Structure:
Properties
Flash Point:	194°C
Boiling Point:	598.4°C at 760 mmHg
Density:	1.33g/cm³
Refractive index:	1.582
Flash Point:	194°C
Safety Data

Other Product

3,5,6,10,16-pentahydroxygrayanotoxan-14-yl hexopyranoside
(3beta,6beta)-3,5,6,10,16-pentahydroxygrayanotoxan-14-yl 3-chloropropanoate
1/C15H13NO/c1-2-16-14-6-4-3-5-12(14)13-9-11(10-17)7-8-15(13)16/h3-10H,2H2,1H
(3beta,6beta)-3,5,6,9,16-pentahydroxygrayanotoxan-14-yl butanoate
(3beta,6beta)-3,5,6,10,16-pentahydroxygrayanotoxan-14-yl hexanoate
(3beta,6beta)-3,5,6,10,16-pentahydroxygrayanotoxan-14-yl benzoate
1/C13H15NO2/c15-8-10-7-9-3-1-5-14-6-2-4-11(12(9)14)13(10)16/h7-8,16H,1-6H
1/C14H9Br2O2P/c15-11-6-8-13(17-11)19(10-4-2-1-3-5-10)14-9-7-12(16)18-14/h1-9
(6alpha,9xi,11beta,16beta)-6,9-difluoro-11-hydroxy-16-methyl-17-[(methylsulfanyl)carbonyl]-3-oxoandrosta-1,4-dien-17-yl propanoate
1/C11H9N5O/c1-17-6-2-3-8-9(4-6)16-11(14-8)7(5-12)10(13)15-16/h2-4,14H,1H3,(H2,13,15
1/C15H22O3/c1-9-10(2)14-12(11(3)13(9)17)5-6-15(4,18-14)7-8-16/h16-17H,5-8H2,1-4H
(7alpha,17beta)-7-methyl-3-oxoandrost-4-en-17-yl propanoate
1/C14H12NS/c1-2-6-12(7-3-1)10-15-11-16-14-9-5-4-8-13(14)15/h1-9,11H,10H2/q+
1/C14H19NO2/c1-3-12-10-17-9-8-15(12)14-7-5-4-6-13(14)11(2)16/h4-7,12H,3,8-10H2,1-2H
1/C14H15O3P/c15-18(16-11-13-7-3-1-4-8-13)17-12-14-9-5-2-6-10-14/h1-10,18H,11-12H
Spiro[cyclopentane-1,2'-[9,4](epoxypentadeca[1,11,13]trienimino)[2H]furo[2',3':7,8]naphth[1,2-d]imidazole]-10',26'(9'H)-dione,16'-(acetyloxy)-1',3'-dihydro-5',6',18',20'-tetrahydroxy-14'-methoxy-7',9',15',17',19',21',25'-heptamethyl-,[9'S-(9'R*,12'E,14'R*,15'S*,16'R*,17'S*,18'S*,19'S*,20'R*,21'R*,22'E,24'Z)]-(9CI)
Spiro[cyclohexane-1,2'-[9,4](epoxypentadeca[1,11,- 13]trienimino)[2H]furo[2',3':7,8]naphth[1,2-d]- imidazole]-10',26'(9'H)-dione,16'-(acetyloxy)- 1',3'-dihydro-5',6',18',20'-tetrahydroxy-14'- methoxy-7',9',15',17',19',21',25'-heptamethyl-,(9'S,12'E,14'S,15'R,16'S,17'R,18'R,19'R,20'S,- 21'S,22'E,24'Z)-
1/C12H10N4O3/c1-3-19-12(18)10-9(7(2)17)6-14-11-8(4-13)5-15-16(10)11/h5-6H,3H2,1-2H
1/C13H19NO2/c1-9(15)6-7-10-8-13(16-14-10)11-4-2-3-5-12(11)13/h11-12H,2-8H2,1H
1/C14H16O4/c1-5-10-12-9(14(15)18-10)6-7-11(16-4)13(12)17-8(2)3/h5-8,10H,1H2,2-4H